ANT Neuro

ANT Neuro operates at the intersection of medical devices, neuroscience research, and clinical neurodiagnostics. Its differentiation is breadth: the portfolio spans EEG amplifiers, gel and dry-electrode caps, mobile and high-density recording, TMS neuronavigation, neurofeedback, neonatal monitoring, fNIRS, and research software. This gives ANT Neuro a broader workflow footprint than a vendor focused only on conventional EEG hardware. The company also addresses both research laboratories and healthcare professionals, with products supporting BCI, sleep studies, neurodiagnostics, neonatal care, multimodal experiments, and personalized stimulation workflows. Relative to single-purpose EEG suppliers, ANT Neuro’s strongest apparent advantages are system modularity, portability, real-time data access, multiple electrode formats, and integration with TMS, focused ultrasound, and functional mapping. Its competitive constraints are less visible: public information does not establish market share, installed base, revenue scale, reimbursement adoption, or comparative clinical evidence. The company is private and categorized as a medical-device and neuroscience business.

ANT Neuro’s trajectory appears to reflect steady product-line expansion rather than a publicly documented venture-funded scaling cycle. Founded in 1996, the company has developed a portfolio that now extends from core EEG acquisition into dry and mobile recording, real-time research workflows, neonatal aEEG monitoring, TMS and focused-ultrasound navigation, neurofeedback, and wearable fNIRS. The eego line provides a clear scalability inflection point, ranging from 8- and 24-channel configurations to 64-, 128-, and 256-channel systems, while the company’s software and SDK support LSL streaming, TTL synchronization, BCI, and multimodal studies. The addition of products such as vm​​ove robot-assisted coil positioning, nëo neonatal monitoring, HiveOne wearable fNIRS, and asa analysis software indicates movement toward integrated clinical and research workflows. Current staffing is categorized at approximately 11–50 employees, with two recorded current leadership positions. No hiring surge, layoffs, funding round, revenue trend, or dated expansion milestone is documented.